Viewing Study NCT03406156


Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2025-12-25 @ 9:16 PM
Study NCT ID: NCT03406156
Status: COMPLETED
Last Update Posted: 2024-08-06
First Post: 2018-01-16
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy
Sponsor: AbbVie
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: M16-788
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators